Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours Β· Estimated delivery Oct 4 - Oct 9
About Enicepatide (CT-388) Enicepatide is an investigational once-weekly subcutaneous injectable, dual GLP-1/GIP receptor agonist being developed for the treatment of people living with obesity and associated comorbidities including type 2 diabetes (T2D)
A: You can incorporate collagen through supplements, such as our Collagen Peptides, bone broth, or collagen-infused hair products
[Accessed 5 September 2025]
Thyroid conditions : Generally safe in treated hypothyroidism, but not suitable for patients with a history of thyroid cancer (MTC or MEN2)
US$ 22.55
US$ 29.00
US$ 28.32
US$ 20.68
US$ 24.12
